Paper
12 July 1994 Suppression of neointimal hyperplasia by photodynamic therapy: in vitro and in vivo results
Mohammed S. Sobeh, Philip Chan, Stephen E. Greenwald, Robert J. Ham, Alan J. Wood, Frank W. Cross M.D., York N. Hsiang M.D.
Author Affiliations +
Abstract
Proliferation of vascular smooth muscle cells (VSMCs) is the pathophysiogical basis of the restenoses which occur in 30-55% of patients undergone revascularisation. Prophylactic measures including pharmacotherapy, endovascular stenting and anti-gene therapy have so far failed to contain this problem. Photodynamic therapy (PDT) may selectively suppress VSMCs and decrease restenosis rates. We report 2 studies; the first examines the effect of PDT on an in-vitro model of NIH and the second involves using endoluminal ablation of an in-vivo model of experimental NIH of the rabbit's aorta.
© (1994) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Mohammed S. Sobeh, Philip Chan, Stephen E. Greenwald, Robert J. Ham, Alan J. Wood, Frank W. Cross M.D., and York N. Hsiang M.D. "Suppression of neointimal hyperplasia by photodynamic therapy: in vitro and in vivo results", Proc. SPIE 2130, Diagnostic and Therapeutic Cardiovascular Interventions IV, (12 July 1994); https://doi.org/10.1117/12.179929
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Photodynamic therapy

In vitro testing

In vivo imaging

Veins

Arteries

Surgery

Chlorine

Back to Top